Will CAR T cell therapy have a role in AML? Promises and pitfalls
Author:
Funder
Novartis Pharmaceuticals
Tmunity Therapeutics
Publisher
Elsevier BV
Subject
Hematology
Reference64 articles.
1. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N Engl J Med,2014
2. Safety and Response of Incorporating CD19 Chimeric Antigen Receptor T Cell Therapy in Typical Salvage Regimens for Children and Young Adults with Acute Lymphoblastic Leukemia;Lee;Blood,2015
3. CAR T cell immunotherapy for human cancer;June;Science,2018
4. The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy;Buckley;Blood Cancer Journal,2015
5. Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients;Wirk;Mycopathologia,2009
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Circ_0012152 Accelerates Acute Myeloid Leukemia Progression through the miR-652-3p/SOX4 Axis;Current Medical Science;2024-06
2. Chimeric antigen receptor T-cell therapy in childhood acute myeloid leukemia: how far are we from a clinical application?;Haematologica;2024-05-10
3. Advances in molecular targeted drugs in combination with CAR-T cell therapy for hematologic malignancies;Drug Resistance Updates;2024-05
4. Recent advances in CAR‐T cell therapy for acute myeloid leukaemia;Journal of Cellular and Molecular Medicine;2024-05
5. Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia;Blood;2024-04-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3